FGF23 and mineral metabolism disease: Klotho-deficient mice exhibited mineral metabolism disorders, including phosphate retention, hypercalcemia; VC, valve calcification; and elevated fibroblastic growth factor-23 (FGF23) levels (Kuro-o et al., 1997).